The FDA has updated Actos label warnings with additional study information and reinforced its belief that the diabetes drug's side effects may increase the risk of bladder cancer.
A new study has found that the use of Actos increases the risk of bladder cancer by 63%, and that the risks appear to be specific to that drug.
Researchers warn that while Actos may prevent diabetes in some cases, users face an increased risk of bone fractures, weight gain and edema.
Side effects of Actos may increase the risk of bladder cancer. Lawsuits are pending nationwide.
An undisclosed settlement ends an Actos bladder cancer trial that has been ongoing since late August and follows a larger settlement agreement affecting thousands of cases.
A $2.4 billion Actos settlement can go forward now that enough plaintiffs have agreed to participate, the manufacturer has announced.
A new Actos trial is under way in Las Vegas, over claims that warnings were withheld about the risk of bladder cancer.
Doctors should individualize diabetes drug treatments for patients with a high risk of heart disease, due to the varying levels of cardiovascular risk associated with certain diabetes drugs, according to…
A new study finds a link between Actos and cancers of the pancreas and prostate, even while dismissing links between the drug and bladder cancer.
A California appeals court has ruled that a judge wrongly overturned a $6.5 million verdict against Takeda Pharmaceuticals over claims that Actos caused bladder cancer.
